Prentiss Christopher B 4
4 · Adamas Pharmaceuticals Inc · Filed Mar 19, 2020
Insider Transaction Report
Form 4
Prentiss Christopher B
Chief Accounting Officer
Transactions
- Award
Common Stock
2020-03-17+10,000→ 80,940 total
Footnotes (1)
- [F1]The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest on January 31, 2021.